The University of Chicago Header Logo

Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia.

Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst. 1992 Jan 15; 84(2):98-103.

View in: PubMed